<p>John Altman of Emory University in the U.S. will research whether a drug which induces lymphopenia and is currently in clinical trials can effectively reduce T-cell exhaustion and induce immune-mediated clearance of the SIV infection.</p>


John Altman of Emory University in the U.S. will research whether a drug which induces lymphopenia and is currently in clinical trials can effectively reduce T-cell exhaustion and induce immune-mediated clearance of the SIV infection.